Beclin 1, Autophagy Related (BECN1) antibody
| Antigen | Beclin 1, Autophagy Related (BECN1) |
| Synonyms | ATG6, VPS30, beclin1, MGC6843, 4921513J16Rik, 5430417M23Rik, MGC73097, zgc:73097, BECN1, becn1, MGC80672, MGC126978, atg6, vps30, Beclin-1, DKFZp459C0719 |
| Clonality | Polyclonal |
| Host |
Alternatives Sheep |
| Reactivity |
Alternatives Human, Rat (Rattus), Mouse (Murine) |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives Immunohistochemistry (IHC), Western Blotting (WB) |
![]() |
6 references available |
| Catalog no. | ABIN349985 |
| Quantity | 150 µl |
| Price | 454.67 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 7 to 8 Business Days |
Additional Information
| Alternative name | coiled-coil myosin-like BCL2-interacting protein (Beclin-1, BECN1, GT197, ATG6, VPS30) |
| UniProt | Q14457 |
| Immunogen | A synthetic peptide from huamn coiled-coil myosin-like BCL2-interacting protein (Beclin-1, BECN1, GT197, ATG6, VPS30) conjugated to an immunogenic carrier protein has been used as the immunogen. The antigen is homologous in rat and mouse. |
| Format | Lyophilized |
| Description | Autophagy is the process by which endogenous proteins and damaged organelles are destroyed intracellularly.autophagy is postulated to be essential for cell homeostasis and cell remodeling during differentiation, metamorphosis, non-apoptotic cell death, and aging. Reduced levels ofautophagy have been described in some malignant tumors, and a role forautophagy in controlling the unregulated cell growth linked to cancer has been proposed. It may play a role in antiviral host defense. Protects against infection by a neurovirulent strain of Sindbis virus. May play a role inautophagy. SUBCELLULAR LOCATION: Cytoplasm. Golgi apparatus membrane; Peripheral membrane protein. Note: Expressed in dendrites and cell bodies of cerebellar Purkinje cells TISSUE SPECIFICITY: Ubiquitous Also known as: Beclin-1, BECN1, GT197, ATG6, VPS30, beclin1. |
| Specificity | Appears to be specific for Beclin-1. |
Application Details
| Application Notes | IHC, WB. Use at a dilution of 1 : 200 to 1 : 2000. The optimal dilution should be determined by the end user. Not yet tested in other applications. |
| Purity | whole serum |
| Storage | Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles. |
| Research Area | Autophagy |
| Restrictions | For Research Use only |
Publications
|
Rommens, Durocher, McArthur et al.: "Generation of a transcription map at the HSD17B locus centromeric to BRCA1 at 17q21." in: Genomics, Vol. 28, Issue 3, pp. 530-42, 1996 (PubMed).
Aita, Liang, Murty et al.: "Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21." in: Genomics, Vol. 59, Issue 1, pp. 59-65, 1999 (PubMed). Liang, Jackson, Seaman et al.: "Induction of autophagy and inhibition of tumorigenesis by beclin 1." in: Nature, Vol. 402, Issue 6762, pp. 672-6, 2000 (PubMed). Kihara, Kabeya, Ohsumi et al.: "Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network." in: EMBO reports, Vol. 2, Issue 4, pp. 330-5, 2001 (PubMed). Koneri, Goi, Hirono et al.: "Beclin 1 gene inhibits tumor growth in colon cancer cell lines." in: Anticancer research, Vol. 27, Issue 3B, pp. 1453-7, 2007 (PubMed). Lee, Jeong, Yoo et al.: "Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias." in: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, Vol. 115, Issue 12, pp. 1357-63, 2008 (PubMed). |
|
Alternatives
Alternatives for antigen "Beclin 1, Autophagy Related (BECN1)", type "Antibodies"




Alternatives